Harm Reduction Therapeutics

Harm Reduction Therapeutics In The News

The latest stories and news about Harm Reduction Therapeutics, OTC RiVive®, and naloxone

STAT

Higher naloxone doses have no impact on overdose survival, study shows

Feb 8, 2024

Bystander Naloxone Administration: Amounts and Dosages versus EMS Naloxone Administration

Feb 3, 2024

First Shipment of RiVive™ Brings Life-Saving Over-The-Counter Naloxone Nasal Spray One Step Closer to Those Who Need It Most

Dec 18, 2023

Open Society Supports an Innovative Model to Make Naloxone Easier to Access Amidst the U.S. Overdose Crisis

Dec 12, 2023

Narcan Now Available Over-the-counter – What to Know

Sep 5, 2023

Partnership to Save Lives: Harm Reduction Therapeutics to donate 200,000 RiVive™ naloxone doses to Remedy Alliance for free distribution

Aug 17, 2023

A new, cheaper naloxone is coming to pharmacy shelves, funded in part by Purdue Pharma’s bankruptcy

Aug 17, 2023

Harm Reduction Therapeutics

FDA APPROVAL OF RiVIVE™ IS A CRITICAL MILESTONE IN MAKING EMERGENCY TREATMENT OF OPIOID OVERDOSE MORE WIDELY AVAILABLE

Aug 1, 2023

CDC

Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose

Apr 11, 2023

Load More
Load More